期刊文献+

中国胃肠胰神经内分泌肿瘤专家共识 被引量:101

下载PDF
导出
摘要 1907年德国病理学家Obemdorfer首次提出了“类癌(carcinoid)”或“类癌瘤(carcinoidtumor)”这一术语,指的是一组发生于胃肠道和其他器官嗜银细胞的新生物,临床、组织化学和生化特征可因其发生部位不同而异。由于类癌是起源于神经内分泌细胞的肿瘤,能够合成、贮存和分泌生物活性胺、小分子多肽类或肽类激素,故又称为小分子多肽或肽类结构瘤(amineprecursoruptakeanddecarboxyla—tiontumor,APUDtumor,APUDOMA)。
出处 《临床肿瘤学杂志》 CAS 2013年第9期815-832,共18页 Chinese Clinical Oncology
  • 相关文献

参考文献95

  • 1Modlin IM, Kidd M, Pfragner R, et al. The functional character- ization of normal and neoplastic human enterochromaffin cells [J]. J C/in Endocrinol Metab,2006, 91 (6) :2340-2348.
  • 2Yao JC, Hassan M, Phan A, et al. One hundred years after "caz'cinoid" : epidemiology of and prognostic factors for neuroen- docrine tumors in 35,825 cases in the United States[ J]. J Clin Oneo1.2008.26 ( 18 ) :3063 - 3072.
  • 3Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors [ J ]. Cancer,2003,97 (4) :934 - 959.
  • 4ho T, Sasano H, Tanaka M, et al. Epidemiological study of gas- troenteropancreatic neuroendocrine tumors in Japan [ J ]. J Gas- troentero1,2010,45 ( 2 ) : 234 - 243.
  • 5郭林杰,唐承薇.中国胃肠胰神经内分泌肿瘤临床研究现状分析[J].胃肠病学,2012,17(5):276-278. 被引量:77
  • 6Wang YH, Lin Y, Xae L, et al. Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendo- crine neoplasms: A single-institution analysis (1995-2012) in South China[ J] BMC Endocr Disord,2012 ,12 :30.
  • 7Oberg KE. Gastrointestinal neuroendocrine tumors[ J]. Ann On- col ,2010,21 ( Suppl 7 ) : vii 72 - vii 80.
  • 8徐建明.重视对胃肠胰腺神经内分泌肿瘤的认识[J].中华肿瘤杂志,2012,34(2):158-160. 被引量:27
  • 9Jensen RT, Niederle B, Mitry E, et al. Gastrinoma (duodenal and pancreatic ) [ J ]. Neuroendocrinology, 2006,84 ( 3 ) : 173 - 182.
  • 10岳欣,顾锋,夏维波,萧新华,李梅,邢小平,曾正陪,向红丁,连小兰,伍学焱.胰岛素瘤的术前定性及定位诊断99例分析[J].中国实用内科杂志:临床前沿版,2006,26(11):1795-1797. 被引量:16

二级参考文献45

  • 1兰明银,狄茂军,曾少波.胰岛素瘤误诊探讨和诊治——附17例报告[J].消化外科,2004,3(5):336-337. 被引量:4
  • 2朱预.中国胰腺内分泌外科50年胰岛细胞肿瘤的50年[J].中华肝胆外科杂志,2006,12(7):433-435. 被引量:11
  • 3Yaov JC,Hassan M,Phan A,et al.One hundred years after "carcinoid ":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.J Clin Oncol,2008,26(18):3063-3072.
  • 4Yao JC,Shah MH,Ito T,et al.Everolimus for advanced pancreatic neuroendocrine tumors.N Engl J Med,2011,364(6):514-523.
  • 5Raymond E,Dahan L,Raoul JL,et al.Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.N Engl J Med,2011,36(6):501-513.
  • 6Kl(o)ppel G,Couvelard A,Perren A,et al.ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors:towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.Neuroendocrinology,2009,90 (2):162-166.
  • 7Klimstra DS,Modlin IR,Adsay NV,et al.Pathology reporting of neuroendocrine tumors:application of the Delphic consensus process to the development of a minimum pathology data set.Am J Surg Pathol,2010,34(3):300-313.
  • 8Bosman FT,Carneiro F,Hruban RH,et al.WHO classification of tumours of the digestive system.Lyon:IARC Press,2010.
  • 9Oberndorfer S.Karzinoide tumoren des dunndarms.Frankf ZPatrol,1907,1:426-432.
  • 10Williams ED,Siebenmann RE,Sobin LH.Histological typing of endocrine tumours.Geneva:World Health Organization,1980.

共引文献434

同被引文献567

引证文献101

二级引证文献506

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部